D-1868-2019 Class II Terminated

Recalled by Aurolife Pharma, LLC — Dayton, NJ

Recall Details

Product Type
Drugs
Report Date
September 25, 2019
Initiation Date
August 23, 2019
Termination Date
August 16, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 11,928 cartons; b) 288 cartons

Product Description

Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-0008-2) and b) 15-count carton (NDC 70677-0008-1), sunmark, Distributed by McKesson, One Post Street, San Francisco, CA 94104.

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution Pattern

Nationwide in the USA

Code Information

Lot #s: a) 067180016B, Exp 05/21 and b) 067180024F1, Exp 07/21